Lirum Therapeutics (Lirum Therapeutics) Long-Term Debt : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Lirum Therapeutics Long-Term Debt?

Lirum Therapeutics's Long-Term Debt for the quarter that ended in Dec. 2023 was $0.00 Mil.

Lirum Therapeutics's quarterly Long-Term Debt declined from Dec. 2022 ($0.50 Mil) to Sep. 2023 ($0.00 Mil) but then stayed the same from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

Lirum Therapeutics's annual Long-Term Debt increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.50 Mil) but then declined from Dec. 2022 ($0.50 Mil) to Dec. 2023 ($0.00 Mil).

Lirum Therapeutics Long-Term Debt Historical Data

The historical data trend for Lirum Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lirum Therapeutics Long-Term Debt Chart

Lirum Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Long-Term Debt

0.50

Lirum Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Sep23	Dec23
Long-Term Debt	-	-	0.50	-	-

Lirum Therapeutics (NAS:LRTX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Lirum Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Lirum Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Lirum Therapeutics (Lirum Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lirum Therapeutics Inc (NAS:LRTX) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

590 Madison Avenue, 21st Floor, New York, NY, USA, 10022

Website

https://www.lirumtx.com

Lirum Therapeutics Inc is clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development, and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways, and commercial opportunities. Its product candidate, LX-101, formerly 765IGF-MTX, is a novel, clinical-stage, "next generation," precision-engineered targeted therapy directed to the IGF-1R.

Lirum Therapeutics (Lirum Therapeutics) Headlines

No Headlines